|
|
|
4528 ONO PHARMACEUTICAL CO.,LTD.
|
|
| 10/30/2025 12:00 |
2nd Quarter of Fiscal Year 2025 (Ending March 31, 2026) (April 1, 2025 to September 30, 2025) Supplementary Materials (Consolidated IFRS) |
| 10/30/2025 12:00 |
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2026 (IFRS) |
| 10/03/2025 16:00 |
Corporate Governance Report |
| 08/01/2025 12:00 |
Notice concerning the Establishment of Ono Global Reinsurance, Inc. as an Overseas Subsidiary (Specified Subsidiary) |
| 08/01/2025 12:00 |
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026 (IFRS) |
| 07/18/2025 12:00 |
Notice on Completion of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation |
| 07/04/2025 17:00 |
[Delayed]Corporate Governance Report |
| 06/19/2025 16:30 |
Notice of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation |
| 05/22/2025 08:00 |
Notice of Convocation Annual General Meeting 2025 |
| 05/08/2025 12:00 |
Notice regarding Differences in the Non-consolidated Financial Results between the Fiscal Year Ended March 31, 2025 and the Previous Fiscal Year |
| 05/08/2025 12:00 |
Fiscal Year 2024 (April 1, 2024 to March 31, 2025) Supplementary Materials (Consolidated IFRS) |
| 05/08/2025 12:00 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (IFRS) |
| 04/28/2025 16:00 |
Revisions of Consolidated Financial Forecasts |
| 04/07/2025 14:00 |
Changes of the Board of Directors and Corporate Officers |
| 03/24/2025 18:00 |
Corporate Governance Report |
|